Basic Study
Copyright ©The Author(s) 2019.
World J Gastrointest Oncol. Jun 15, 2019; 11(6): 470-488
Published online Jun 15, 2019. doi: 10.4251/wjgo.v11.i6.470
Table 1 Demographic and clinical characteristics of the plasma and wound fluid study population (benign and cancer groups), n (%)
Benign (n = 31)Cancer (n = 35)
Age, yr (mean ± SD)57.3± 14.163.6± 11.3
Sex (n):
Male11 (35.0)21 (60)
Female20 (65.0)14 (40)
Incision length, cm (mean ± SD)8.3 ± 5.39.8 ± 6.0
Operative time, min (mean ± SD)339.1 ± 116.1430.1 ± 121.0
Length of stay, d (mean ± SD)5.6 ± 2.37.7 ± 6.6
Type of resection:
Right6 (19.0)4 (11.0)
Transverse1 (3.0)3 (9.0)
Sigmoid/rectosigmoid15 (48.0)5 (14.0)
LAR/AR4 (13.0)12 (34.0)
APR0 (0.0)9 (26.0)
Hartman takedown with resection2 (7.0)0(0.0)
Total colectomy/proctocolectomy3 (10.0)2 (6.0)
Surgical method:
Laparoscopic-assisted21 (68.0)22 (63.0)
Hand-assisted/hybrid Laparoscopic8 (26.0)9 (26.0)
Open2 (6)4 (11)
Table 2 Range of mean % of increase of plasma proteins during post-operative period from pre-operative mean value
BenignMalignant
ANG-249-10138-70
VEGF64-169104-202
MMP-219-3916-37
PLGF36-5529-53
MMP-360-16243-143
OPN85-187108-146
MCP-128-34444-63
CHI3L145-946196-1006
Table 3 The fall increased in wound fluid per corresponding mean plasma levels
Analyzed proteinThe fall increased in wound fluid per corresponding mean plasma levelsIncreased range
benigncancerbenigncancerbenigncancerbenigncancerbenigncancer
POD1POD1POD3POD3POD7-13POD7-13POD14-20POD14-20
ANG-23.33.05.56.012.812.08.03.53-133-12
VEGF15.519.022.936.059.061.060.5106.016-6119-106
MMP-20.962.01.82.04.54.04.53.31-52-4
PLGF40.816.088.261.0100.346.0106.127.241-10616-61
MMP-32.65.24.65.06.53.28.85.43-93.2-5.3
OPN4.93.114.012.024.214.015.59.35-233.1-14
MCP-139.740.074.737.085.259.016.057.116-8637-59
CHI3L10.60.76.93.05.79.03.65.01-73-9